Reports
Sale
Global Contraceptive Pills Market Share, Size, Analysis, Forecast: By Type: Progestin Pills, Combination Pills; By Drug Type: Generics, Branded; By Therapy Type: Monotherapy, Combined Contraceptives; By Age Group: 15-45 Years, Above 45 Years; By Distribution Channel: Hospital Pharmacy, Others; Regional Analysis; Competitive Landscape; 2024-2032
Global Contraceptive Pills Market Outlook
The global contraceptive pills market size reached a value of USD 18.66 billion in 2023. The market is further expected to grow at a CAGR of 3.92% during the forecast period of 2024-2032, likely to attain a value of USD 26.35 billion by 2032. The growth of the market is likely to be driven by the rapid technological developments.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be Among the Significant Regional Markets for Contraceptive Pills
North America is anticipated to account for a significant share of the global contraceptive pills market in the forecast period. The region is projected to uphold its dominance throughout the forecast period, owing to the high incidence of unintended pregnancies, rise in awareness regarding contraceptive pills, the surge in adoption of modern contraceptive drugs, and an alarming increase in the prevalence of sexually transmitted diseases, such as HIV/AIDS. The United States controls a significant portion of the North American contraceptive pill market. The United States government has initiated several awareness programs about contraception and family planning, which has fuelled the industry's revenue. Several organisations are also working in the country to accomplish strategic projects. According to data published by the Bill & Melinda Gates Foundation in 2023, the foundation plans to spend USD 280 million per year from 2021 to 2030 on developing new and improved contraceptive technologies, supporting family planning programmes that reflect local community preferences, and allowing women and girls to be in control of their contraceptive care.
Due to a large population base and proactive activities by governmental organisations for birth control and awareness within developing countries, Asia Pacific is expected to increase at the fastest rate during the projected period. In addition, the availability of cost-effective contraceptive pills in this region proposes profitable opportunities for contraceptive drug manufacturers. The launch of awareness programs by government agencies and other regulatory bodies to increase the homecare usage of contraceptive pills is likely to drive the contraceptive pills market in the Asia Pacific region.
Market Segmentations
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The contraceptive pill, also known as the birth control pill, is a kind of birth control administered orally to women. It contains an oestrogen and a progestogen combination (specifically a progestin). When used correctly, it disrupts the menstrual cycle, preventing ovulation and pregnancy.
By type, the market includes:
- Progestin-only Pills
- Combines Contraceptives Pills
The several distribution channels of the market are:
- Online Pharmacy
- Hospital Pharmacy
- Retail Pharmacy
- Public Channel and NGO
- Clinics
- Others
The regional markets for the contraceptive pills industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Awareness Among People Augmenting the Market Growth
The rising awareness among consumers about sexual health is expected to increase the demand and adoption of birth control methods, thereby augmenting the growth of contraceptive pills market. The upsurge in contraception has reduced the risk of sexually transmitted infections and enhanced health-related outcomes, comprising maternal and infant mortality. The rise in awareness of modern contraceptives, increasing use of safe and effective oral pills, and health complications related to teenage pregnancies further stimulate market expansion. Also, various government programs have increased access to contraceptives, which help prevent unwanted pregnancies in teenagers. Development, approval, and commercialisation of new, more effective, and long-acting reversible contraceptive methods are expected to drive the industry growth during the forecast period. For instance, Agile Therapeutics developed a hormonal patch, Twirla, introduced in the United States in the fourth quarter of 2020. The launch of generic and low-cost drugs and devices has led to an increase in the demand for contraceptives by teenagers. Further, the rising number of unwanted pregnancies is also one of the major factors driving the demand for contraceptive pills, thereby contributing to the market growth.
Key Players in the Global Market for Contraceptive Pills
The report gives a detailed analysis of the following key players in the global contraceptive pills market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Janssen Global Services, LLC
- Pfizer Inc.
- Teva Pharmaceuticals Industry Ltd.
- Merck & Co. Inc.
- Allergan, plc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Drug Type |
|
| Breakup by Therapy Type |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Contraceptive Pills Market Overview
3.1 Global Contraceptive Pills Market Historical Value (2017-2023)
3.2 Global Contraceptive Pills Market Forecast Value (2024-2032)
4 Global Contraceptive Pills Market Landscape
4.1 Global Contraceptive Pills Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Contraceptive Pills Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Drug Type
4.2.3 Analysis by Age Group
4.2.4 Analysis by Therapy Type
4.2.5 Analysis by Distribution Channel
5 Global Contraceptive Pills Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Contraceptive Pills Market Segmentation
6.1 Global Contraceptive Pills Market by Type
6.1.1 Market Overview
6.1.2 Progestin Pills
6.1.3 Combination Pills
6.1.3.1 Monophasic
6.1.3.2 Triphasic
6.1.3.3 Others
6.2 Global Contraceptive Pills Market by Drug Type
6.2.1 Market Overview
6.2.2 Generics
6.2.3 Branded
6.3 Global Contraceptive Pills Market by Therapy Type
6.3.1 Market Overview
6.3.2 Monotherapy
6.3.3 Combined Contraceptives
6.4 Global Contraceptive Pills Market by Age Group
6.4.1 Market Overview
6.4.2 15-45 Years
6.4.3 Above 45 Years
6.5 Global Contraceptive Pills Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Hospital Pharmacy
6.5.3 Retail Pharmacy
6.5.4 Online Channel
6.5.5 Public Channel
6.5.6 Others
6.6 Global Contraceptive Pills Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Contraceptive Pills Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Contraceptive Pills Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Contraceptive Pills Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Contraceptive Pills Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Contraceptive Pills Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Piramal Enterprises Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Agile Therapeutics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Johnson & Johnson Services, Inc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Abbive Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck & Co Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Teva Pharmaceuticals Industries Ltd.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bayer AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Pfizer Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Helm AG.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Reckitt Benckiser Group PLC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Viatris Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Amneal Pharmaceuticals LLC
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Bayer AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Allergan plc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Agile Therapeutics
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Contraceptive Pills Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global contraceptive pills market attained a value of nearly USD 16.72 billion.
The market is projected to grow at a CAGR of 8.90% between 2024 and 2032.
The major drivers of the market include the rise in the prevalence of sexually transmitted diseases, large population base, rise in awareness of modern contraceptives, increasing use of safe and effective oral pills, various government programs, commercialisation of new, more effective, and long-acting reversible contraceptive.
The rising awareness about sexual health and the increasing number of unwanted pregnancies are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The different types of contraceptive pills include progestin-only pills and combined contraceptive pills.
The several distribution channels of the market include online pharmacy, hospital pharmacy, retail pharmacy, public channel and NGO, and clinics, among others.
The major players in the industry are Janssen Global Services, LLC, Pfizer Inc., Teva Pharmaceuticals Industry Ltd., Merck & Co. Inc., and Allergan, plc, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER